Background A serological test that could help to diagnose tuberculosis, especially smear negative disease, would contribute to patient management.
Conclusion Antigen or epitope specific serology may help in the diagnosis, assessment of prognosis, and monitoring of chemotherapy in patients with pulmonary tuberculosis.
Tuberculosis remains an important health problem in the United Kingdom. ' 2 The decline in incidence has slowed3 and diagnosis has become more difficult because of atypical presentations and a lack of familiarity with the disease among doctors.4 The mortality from tuberculosis has remained constant for the past decade at about 10%' (A Fenton-Lewis, personal communication). The diagnosis of tuberculosis is readily made when a sputum smear contains acid fast bacilli. Subsequent culture will usually identify those patients with tuberculosis and those infected with other mycobacterial species after a delay of three to nine weeks. Clinical features that identify patients with a risk of greater morbidity include increasing age, alcoholism, neutrophilia and lymphopenia, and delayed diagnosis.56 Severe or extensive disease is associated with a reduced tuberculin response.7 Short course chemotherapy for tuberculosis still lasts for six months and poor compliance with treatment is a common problem."'0 A serological test capable of diagnosing smear negative tuberculosis, and also cases in which sputum is difficult to obtain, would be very helpful.
The usefulness of determining antibodies in tuberculosis has been largely dismissed since Isoniazid resistance Isoniazid resistant strains of M tuberculosis were grown from six patients, four of whom had recurrent tuberculosis. Titres of antibody to all the epitopes except for TB23 rose more slowly after treatment in these patients than in those from whom fully sensitive strains were cultured; significant differences were observed at two weeks (in all cases t <-2 3, p < 0 04). Titres of antibody to the TB72 epitope of the 38 kDa protein at two weeks had fallen below pretreatment levels in all subjects with isoniazid resistant strains, a fall that occurred in only two patients with fully sensitive strains of M tuberculosis (x2 = 4 2, p = 0 04).
Non-tuberculous mycobacteria
Four patients were infected with atypical mycobacteria (one with M aviumintracellulare, one with M kansasii, and two with M xenopi). One patient had a myeloma, but the other three had no evidence of immunosuppression and all were negative for HIV antigen and antibody. Two patients had weakly positive titres of antibody (2-3 SD above the log mean of control values-to the TB68 and TB78 epitopes respectively) at the start of treatment; none was positive for the TB71 and TB72 epitopes of the 38 kDa antigen. No patient with atypical mycobacterial infection had a positive titre of antibody to any of the six epitopes two weeks after treatment had begun.
Discussion
This study has shown that M tuberculosis restricted antigens can be used in the serological diagnosis of pulmonary tuberculosis. The serological test was as sensitive as but more specific than the use of tuberculin and could distinguish non-tuberculous mycobacterial disease from tuberculosis by the absence of anti-38 kDa antibody and no rise in levels of antibody to other M tuberculosis specific epitopes and could detect patients with smear negative pulmonary tuberculosis before the results of sputum culture were available. In smear positive pulmonary tuberculosis, most patients had high titres of antibody to the 38 kDa antigen, confirming the results of previous studies.""'9"24 The 38 kDa antigen is also contained in the antigen 5 preparation""26 and is of value in serological diagnosis and screening for infectious tuberculosis.27"32 Serological tests in smear negative pulmonary tuberculosis have been disappointing."-35 Our study is the first to show that a combination of antigens can achieve a sensitivity in smear negative pulmonary tuberculosis similar to that tNon-compliance was associated with a rise in the titre of antibody to the TB68 epitope.
+Isoniazid resistance was associated with a fall in the titre of antibody to the TB72 epitope.
LAM-lipoarabinomannan; NS-no significant association.
of tuberculin testing but with greater specificity.
The use of monoclonal antibodies is an advance in the serological diagnosis of tuberculosis because they are readily prepared in a standard form, are free from the problems of cross reactivity, permit the measurement of both IgM and IgG antibodies in a single assay, and obviate the need to purify antigens from M tuberculosis. Indeed, the TB72 competition assay fared as well as the use of purified 38 kDa antigen in the serodiagnosis of smear positive tuberculosis. An ELISA modification of the competition assay3l can give a result in four hours with precoated plates and has been used successfully in the diagnosis of extrapulmonary tuberculosis. 37 The cost of such an assay would be similar to that of an autoantibody screen. In smear negative pulmonary tuberculosis, however, purified 19 kDa antigen will be needed until the epitope, which is not that defined by the MAB TB23, has been identified.
High titres of antibody to the 38 kDa antigen were associated with more extensive and recurrent tuberculosis and increased mortality as well as being largely confined to those with smear positive disease whereas antibody to the 14 kDa antigen was associated with a good prognosis and less radiographic infiltration in patients with self healed pulmonary tuberculosis (table 4) . Antibody titres for these two antigens were more successful than a scoring system based on clinical criteria,6 or the factors of advanced age and alcoholism, in predicting who would be at greatest risk from tuberculosis. Inpatient treatment of tuberculosis is increasingly rare and the identification of patients at greatest risk would be valuable in deciding which patients require hospital admission.
The treatment of tuberculosis is necessarily prolonged and compliance is a problem. This study suggests that titres of antibody to the TB68 epitope of the 14 kDa antigen could be used to monitor compliance by indicating those who had become culture positive again; such patients might then electively receive supervised chemotherapy. Isoniazid resistant strains of M tuberculosis were associated with a failure of antibody titres to rise after two weeks' treatment; adding other drugs to the standard regimen of rifampicin, isoniazid, and pyrazinamide could be considered in such patients. Non-tuberculous mycobacterial infections were associated with an absence of anti-38 kDa antibody despite a positive sputum smear. M kansasii and M xenopi are the two most commonly isolated non-tuberculous mycobacterial species in the London area37 and are usually resistant to pyrazinamide and isoniazid. While bacteriological confirmation is awaited, this group of patients could also receive ethambutol or streptomycin, or both-drugs recommended for the treatment of non-tuberculous mycobacterial infections3 0-in addition to standard triple chemotherapy.
The measurement of titres of antibody to M tuberculosis specific antigens may be of value in the diagnosis of both smear positive and smear negative pulmonary tuberculosis. Antibody titres may also help to determine which patients should be treated in hospital, which require supervised chemotherapy, and which might require the addition of other drugs to the standard regimen for the treatment of tuberculosis. This study has established which antigens or their epitopes might be of value in the management of patients with tuberculosis, together with cut off titres. Prospective evaluation of the role of serology, comparing patients whose antibody titres affected clinical management with patients where antibody levels were not known, together with a cost-benefit analysis, is essential before widespread use of these tests can be recommended.
